株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のウイルス除去市場:考察、市場機会、分析、市場シェア、予測

Global Virus Filteration Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2024

発行 Occams Business Research & Consulting Pvt. Ltd. 商品コード 621140
出版日 ページ情報 英文
納期: お問合せ
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
世界のウイルス除去市場:考察、市場機会、分析、市場シェア、予測 Global Virus Filteration Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2024
出版日: ページ情報: 英文
概要

当レポートでは、世界のウイルス除去市場について調査し、産業および市場の概要、製品タイプ・技術・用途・エンドユーザー・地域別の市場動向、市場規模の推移と予測、市場促進・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査概要

  • 世界のウイルス除去市場:発展と変遷
  • 市場の定義と範囲
  • 産業構造
  • 市場分析
  • 予測分析
  • 戦略分析
    • 投資 vs 導入モデル
    • 全方位的産業分析
    • ファイブフォース分析
    • シーソー分析
    • 消費者分析と主な購入基準
  • 競合分析
    • 主要戦略と分析
    • 市場シェアおよび上位企業の分析
  • 戦略提言と総論
    • 地域別の投資機会
    • 新規分野の市場機会
    • 急成長市場の投資機会

第3章 市場の決定要因

  • 促進要因
  • 阻害要因
  • 市場機会
  • 課題

第4章 市場区分

  • ウイルス除去市場:製品タイプ別
    • 消耗品
    • 装置
    • サービス
  • ウイルス除去市場:技術別
    • フィルター
    • クロマトグラフィー
  • ウイルス除去市場:用途別
    • 生物学的製剤
    • 医療機器
    • 浄水
    • 空気清浄
  • ウイルス除去市場:エンドユーザー別
    • バイオ製薬・バイオテクノロジー企業
    • CRO(医薬品開発業務受託機関)
    • 医療機器メーカー
    • 学術研究機関

第5章 競合情勢

  • 主な戦略
    • 合併・買収の一覧
    • 合弁事業の一覧
    • 発売製品の一覧
    • 事業提携の一覧

第6章 地域分析

  • 意思支援決定データベース・推計手法
  • 市場セグメントの比較分析
  • 市場機会のマトリクス
  • 地域区分
    • 北米(米国、カナダ)
    • 欧州(英国、フランス、ドイツ、スペインなど)
    • アジア太平洋(中国、インド、日本、オーストラリアなど)
    • その他の地域(ラテンアメリカ、中東・アフリカ)

第7章 企業プロファイル

  • ARGONIDE
  • 旭化成メディカル
  • CHARLES RIVER LABORATORIES
  • CLEAN CELLS INC.
  • DANAHER CORPORATION
  • GE HEALTHCARE
  • LENNTECH
  • LONZA GROUP
  • MERCK GROUP
  • PENDOTECH
  • SARTORIUS AG
  • THERMO FISHER SCIENTIFIC
  • WUXI PHARMATECH (CAYMAN) INC.
図表

LIST OF TABLES

  • 1. GLOBAL VIRUS FILTRATION MARKET BY PRODUCT 2014-2023 ($ MILLION)
  • 2. GLOBAL CONSUMABLES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 3. GLOBAL VIRUS FILTRATION MARKET BY CONSUMABLES 2014-2023 ($ MILLION)
  • 4. GLOBAL INSTRUMENTS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 5. GLOBAL VIRUS FILTRATION MARKET BY INSTRUMENTS 2014-2023 ($ MILLION)
  • 6. GLOBAL SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 7. GLOBAL VIRUS FILTRATION MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
  • 8. GLOBAL FILTRATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 9. GLOBALCHROMATOGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 10. GLOBAL VIRUS FILTRATION MARKET BY APPLICATION 2014-2023 ($ MILLION)
  • 11. GLOBAL BIOLOGICALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 12. GLOBAL VIRUS FILTRATION MARKET BY BIOLOGICALS 2014-2023 ($ MILLION)
  • 13. GLOBAL MEDICAL DEVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 14. GLOBAL WATER PURIFICATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 15. GLOBAL AIR PURIFICATION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 16. GLOBAL VIRUS FILTRATION MARKET BY END USERS 2014-2023 ($ MILLION)
  • 17. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 18. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 19. GLOBAL MEDICAL DEVICES COMPANIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 20. GLOBAL ACADEMIC INSTITUTES & RESEARCH LABORATORIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • 21. NORTH AMERICA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 22. EUROPE VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 23. ASIA PACIFIC VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 24. REST OF THE WORLD VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CONSUMABLESMARKET 2014-2023 ($ MILLION)
  • 2. GLOBAL KITS AND REAGENTSMARKET 2014-2023 ($ MILLION)
  • 3. GLOBAL OTHERSMARKET 2014-2023 ($ MILLION)
  • 4. GLOBAL INSTRUMENTSMARKET 2014-2023 ($ MILLION)
  • 5. GLOBAL FILTRATION SYSTEMSMARKET 2014-2023 ($ MILLION)
  • 6. GLOBAL CHROMATOGRAPHY SYSTEMSMARKET 2014-2023 ($ MILLION)
  • 7. GLOBAL SERVICESMARKET 2014-2023 ($ MILLION)
  • 8. GLOBAL FILTRATIONMARKET 2014-2023 ($ MILLION)
  • 9. GLOBAL CHROMATOGRAPHYMARKET 2014-2023 ($ MILLION)
  • 10. GLOBAL BIOLOGICALMARKET 2014-2023 ($ MILLION)
  • 11. GLOBAL VACCINES AND THERAPEUTICSMARKET 2014-2023 ($ MILLION)
  • 12. GLOBAL BLOOD AND BLOOD PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 13. GLOBAL CELLULAR AND GENE THERAPY PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 14. GLOBAL TISSUE AND TISSUE PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 15. GLOBAL STEM CELL PRODUCTSMARKET 2014-2023 ($ MILLION)
  • 16. GLOBAL MEDICAL DEVICESMARKET 2014-2023 ($ MILLION)
  • 17. GLOBAL WATER PURIFICATIONMARKET 2014-2023 ($ MILLION)
  • 18. GLOBAL AIR PURIFICATIONMARKET 2014-2023 ($ MILLION)
  • 19. GLOBAL BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIESMARKET 2014-2023 ($ MILLION)
  • 20. GLOBAL CONTRACT RESEARCH ORGANIZATIONSMARKET 2014-2023 ($ MILLION)
  • 21. GLOBAL MEDICAL DEVICES COMPANIESMARKET 2014-2023 ($ MILLION)
  • 22. GLOBAL ACADEMIC INSTITUTES & RESEARCH LABORATORIESMARKET 2014-2023 ($ MILLION)
  • 23. UNITED STATES (U.S.) VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 24. CANADA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 25. UNITED KINGDOM (UK) VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 26. FRANCE VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 27. GERMANY VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 28. SPAIN VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 29. ROE VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 30. INDIA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 31. CHINA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 32. JAPAN VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 33. AUSTRALIA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 34. ROAPAC VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 35. LATIN AMERICA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
  • 36. MENA VIRUS FILTRATION MARKET 2014-2023 ($ MILLION)
目次

Virus filtration technology is majorly used for removal of viruses such as tailed viruses, deformable bacteria, etc. The global virus filtration market is expected to rise with the CAGR of about 12% during forecast period. Rising demand for biological products such as vaccines, cellular & gene therapy, etc. is one of the major factor which contributes to growth of global virus filtration market during forecast period. Also, growth in pharmaceutical industry as well as rise in research &development in biologic contributes to the market growth. However, stringent regulations for validation of filtration products and highly consolidated market are the factors restraining growth of virus filtration market during forecast period.

Geographically, North America accounted for the largest market share in terms of revenue in 2016 for the virus filtration market followed by Asia Pacific and Europe. North America is expected to dominate the market in terms of revenue during the forecast period due to growth of pharmaceutical industry across the region. However, Asia Pacific is expected to be the fastest growing region in terms of revenue in virus filtration market during the forecast period. Highest growth rate in Asia Pacific virus filtration market is majorly witnessed due to increasing pharmaceutical outsourcing in Asia Pacific during the forecast period.

The growth in global virus filtration market is also influenced by the presence of major players such asMerck group (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific (U.S.), Wuxi Pharmatech (Cayman) Inc. (China), etc. Product launches, mergers & acquisitions, joint ventures, collaboration etc. are some crucial strategies that are adopted by the major players to gain competitive advantage.

Global virus filtration market report covers segmentation analysis of product, technology, application and end users. Report further covers segments of product which include consumables, instruments and services. Consumables accounted for the largest market revenue share in 2016 and it is expected to dominate the market during the forecast period due to increased usage of consumables such as reagents, membranes, etc. in biologic downstream processing. Technologies involved in virus filtration include filtration and chromatography. Further, applications of virus filtration include biological, medical devices, water purification and air purification. Chromatography is expected to be the fastest growing segment during the forecast period due to advancements in product such as development of singleuse membranes. Furthermore, the end users adopting virus filtration include biopharmaceutical & biotechnology companies, contract research organizations, medical devices companies and academic institutes & research laboratories.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL VIRUS FILTRATION MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION & SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360-DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 FORCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES & ANALYSIS
    • 2.8.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. GROWTH IN PHARMACEUTICAL INDUSTRY
    • 3.1.2. RISE IN R&D IN BIOLOGIC
    • 3.1.3. GOVERNMENT SUPPORT FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY
    • 3.1.4. INCREASING DEMAND FOR BIOLOGICAL PRODUCTS
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. STRINGENT REGULATIONS FOR VALIDATION OF FILTRATION PRODUCTS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. RISING ADOPTION OF SINGLE-USE TECHNOLOGIES
    • 3.3.2. INCREASING PHARMACEUTICAL OUTSOURCING
  • 3.4. MARKET CHALLENGES
    • 3.4.1. HIGHLY CONSOLIDATED MARKET

4. MARKET SEGMENTATION

  • 4.1. GLOBAL VIRUS FILTRATION MARKET BY TYPE OF PRODUCT
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBALCONSUMABLESMARKET
        • 4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.4. KEY CONCLUSIONS
        • 4.1.5.1.5. MARKET SUB-SEGMENTS
          • 4.1.5.1.5.1. KITS AND REAGENTS
          • 4.1.5.1.5.2. OTHERS
      • 4.1.5.2. GLOBAL INSTRUMENTSMARKET
        • 4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.4. KEY CONCLUSIONS
        • 4.1.5.2.5. MARKET SUB-SEGMENTS
          • 4.1.5.2.5.1. FILTRATION SYSTEMS
          • 4.1.5.2.5.2. CHROMATOGRAPHY SYSTEMS
      • 4.1.5.3. GLOBAL SERVICESMARKET
        • 4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.4. KEY CONCLUSIONS
  • 4.2. GLOBAL VIRUS FILTRATION MARKET BY TECHNOLOGY
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBALFILTRATION MARKET
        • 4.2.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.1.4. KEY CONCLUSIONS
      • 4.2.5.2. GLOBALCHROMATOGRAPHY MARKET
        • 4.2.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.2.4. KEY CONCLUSIONS
  • 4.3. GLOBAL VIRUS FILTRATION MARKET BY APPLICATION
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBALBIOLOGICALMARKET
        • 4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.1.4. KEY CONCLUSIONS
        • 4.3.5.1.5. MARKET SUB-SEGMENTS
          • 4.3.5.1.5.1. VACCINES AND THERAPEUTICS
          • 4.3.5.1.5.2. BLOOD AND BLOOD PRODUCTS
          • 4.3.5.1.5.3. CELLULAR AND GENE THERAPY PRODUCTS
          • 4.3.5.1.5.4. TISSUE AND TISSUE PRODUCTS
          • 4.3.5.1.5.5. STEM CELL PRODUCTS
      • 4.3.5.2. GLOBALMEDICAL DEVICES MARKET
        • 4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.2.4. KEY CONCLUSIONS
      • 4.3.5.3. GLOBALWATER PURIFICATION MARKET
        • 4.3.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.3.4. KEY CONCLUSIONS
      • 4.3.5.4. GLOBALAIR PURIFICATIONMARKET
        • 4.3.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.4.4. KEY CONCLUSIONS
  • 4.4. GLOBAL VIRUS FILTRATION MARKET BY END-USER
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBALBIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET
        • 4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.1.4. KEY CONCLUSIONS
      • 4.4.5.2. GLOBALCONTRACT RESEARCH ORGANIZATIONSMARKET
        • 4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.2.4. KEY CONCLUSIONS
      • 4.4.5.3. GLOBALMEDICAL DEVICES COMPANIESMARKET
        • 4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.3.4. KEY CONCLUSIONS
      • 4.4.5.4. GLOBALACADEMIC INSTITUTES & RESEARCH LABORATORIESMARKET
        • 4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.4.3. KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.4.4. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS AND ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GEOGRAPHIC ANALYSIS

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GLOBAL VIRUS FILTRATION MARKET BY REGION 2014-2023 ($ MILLION)
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. SPAIN
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
        • 6.4.2.2.5. REST OF EUROPE
          • 6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.5.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. AUSTRALIA
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
        • 6.4.3.2.5. REST OF ASIA PACIFIC
          • 6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.5.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ARGONIDE (U.S.)
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. STRATEGIC INITIATIVES
    • 7.1.4. SCOT ANALYSIS
    • 7.1.5. STRATEGIC ANALYSIS
  • 7.2. ASAHI KASEI MEDICAL CO., LTD. (JAPAN)
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. STRATEGIC INITIATIVES
    • 7.2.4. SCOT ANALYSIS
    • 7.2.5. STRATEGIC ANALYSIS
  • 7.3. CHARLES RIVER LABORATORIES (U.S.)
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. STRATEGIC INITIATIVES
    • 7.3.4. SCOT ANALYSIS
    • 7.3.5. STRATEGIC ANALYSIS
  • 7.4. CLEAN CELLS INC. (FRANCE)
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. STRATEGIC INITIATIVES
    • 7.4.4. SCOT ANALYSIS
    • 7.4.5. STRATEGIC ANALYSIS
  • 7.5. DANAHER CORPORATION (U.S.)
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. STRATEGIC INITIATIVES
    • 7.5.4. SCOT ANALYSIS
    • 7.5.5. STRATEGIC ANALYSIS
  • 7.6. GE HEALTHCARE (U.K.)
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. STRATEGIC INITIATIVES
    • 7.6.4. SCOT ANALYSIS
    • 7.6.5. STRATEGIC ANALYSIS
  • 7.7. LENNTECH (THE NETHERLANDS)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. STRATEGIC INITIATIVES
    • 7.7.4. SCOT ANALYSIS
    • 7.7.5. STRATEGIC ANALYSIS
  • 7.8. LONZA GROUP (SWITZERLAND)
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. STRATEGIC INITIATIVES
    • 7.8.4. SCOT ANALYSIS
    • 7.8.5. STRATEGIC ANALYSIS
  • 7.9. MERCK GROUP (GERMANY)
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. STRATEGIC INITIATIVES
    • 7.9.4. SCOT ANALYSIS
    • 7.9.5. STRATEGIC ANALYSIS
  • 7.10. PENDOTECH (U.S.)
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. STRATEGIC INITIATIVES
    • 7.10.4. SCOT ANALYSIS
    • 7.10.5. STRATEGIC ANALYSIS
  • 7.11. SARTORIUS AG (GERMANY)
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. STRATEGIC INITIATIVES
    • 7.11.4. SCOT ANALYSIS
    • 7.11.5. STRATEGIC ANALYSIS
  • 7.12. THERMO FISHER SCIENTIFIC (U.S.)
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. STRATEGIC INITIATIVES
    • 7.12.4. SCOT ANALYSIS
    • 7.12.5. STRATEGIC ANALYSIS
  • 7.13. WUXI PHARMATECH (CAYMAN) INC. (CHINA)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. STRATEGIC INITIATIVES
    • 7.13.4. SCOT ANALYSIS
    • 7.13.5. STRATEGIC ANALYSIS